Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupAcute LeukemiasMyeloproliferative neoplasms (MPN) and myelodysplastic neoplasms (MDS)TransplantationDiseaseAcute Lymphoblastic LeukaemiaAcute Myeloid LeukemiaChronic Myeloid LeukemiaStem Cell Transplantation, AllogeneicSubgroupICD10C91.0-C92.0-C92.1-C92.5-C92.6-C92.7-C92.8-C92.9-C93.0-MeSHHematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaTransplantation ConditioningSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirNo. Substances10Protocol classificationTherapy classificationcurrent standardIntensityKonditionierung, myeloablativ (MAC)Therapy indicationTherapy phaseallogene StammzelltransplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorBlume KGDiseaseAML/ALL/CML, allogene StammzelltransplantationOriginCity of Hope National Medical Center, California, USAProtokolle in Überarbeitung 1 protocol foundEtoposidphosphat 60 / TBI 13,2, allogene Stammzelltransplantation, MAC (PID3221 V1.0)
